Diagnosis of Chronic Brucellosis with Interferon-Gamma Quantification
Sarah Yahya Abdullah 1, Yasir Mufeed Abdulateef 2*, Sawsan Qahtan Taha Al-Quhli 3
Journal of Angiotherapy 8(2) 1-8 https://doi.org/10.25163/angiotherapy.829468
Submitted: 13 December 2023 Revised: 13 February 2024 Published: 18 February 2024
This study showed the improvement of brucellosis diagnosis using interferon-gamma for better detection in chronic cases
Abstract
Background: Brucellosis can vary in severity and duration, requiring multiple tests for diagnosis. Its prevalence in Iraq complicates the interpretation of test results. Objective: This study aimed to develop a diagnostic tool leveraging variations in γ interferon to aid the immune system in recognizing illness. Methods: A comparative study was conducted at Anbar Teaching Hospital from October 2022 to September 2023. 86 blood samples were collected from the outpatient infectious clinic, comprising 43 confirmed Rose Bengal-positive and 43 negative cases. Various diagnostic methods were employed, including specific IgM and IgG antibodies, culture, polymerase chain reaction (PCR), and gamma interferon targeting the brucella antigen. Results: Patients with positive results exhibited symptoms validated by PCR. The gamma interferon assay demonstrated 79.2% sensitivity and 100% specificity. PCR showed 89.3% sensitivity and 100% specificity, while brucella-specific IgG had 21.4% sensitivity and 100% specificity. Other laboratory studies, including Brucella-specific IgM, showed 100% sensitivity and specificity, with positive Brucella culture observed in only one case. Conclusion: Chronic brucellosis's sustained high levels of gamma interferon may offer better follow-up for patients with lingering symptoms than Brucella-specific IgG, especially after acute cases with low-grade fever.
Keywords: Chronic Brucellosis, Interferon Gamma, Sensitivity, Specificity.
References
Abdulah Y. Al-Mahdi, Alabed Ali A. Alabed, Mohammed Faez Baobaid et al., (2024). Antibacterial Activity of Herbal Essential Oils against Gram-positive and Gram-negative Bacteria with a Potential for Multidrug Resistance, Journal of Angiotherapy, 8(2), 1-7, 9517
Aljanabi, Y. M., Lafi, S. A., & Eyada, H. N. (2020). Tb Laboratory diagnosis, A comparative study in Baghdad, IRAQ. 20(4), 855-860.
Al-Khater, B. H. K., Al-Ouqaili, M. T. S., Al-Anii, S. N. (2015). In Term of Molecular Technique, Taxonomic and Diagnostic Aspects of Chronic Human Brucellosis in Ramadi City. Anb Med J, 12(1), 1-12.
Al-Koubaisy, H. N., & Lafi, S. A. (2011). Presentation of brucellosis in an endemic area; west of IRAQ. Egypt. Acad. J. Biol. Sci., 3(1), 13-18.
Alton, G. G., Jones, L. M., Angus, R. D., & Verger, J. M. (1988). Techniques for the brucellosis laboratory. Institut National de la Recherche Agronomique.
Baldwin, C. L., & Goenka, R. (2006). Host immune responses to the intracellular bacteria Brucella: Does the bacteria instruct the host to facilitate chronic infection? Critical Reviews in Immunology, 26(5), 407–442.
Baldwin, C. L., & Parent, M. (2002). Fundamentals of host immune response against Brucella abortus: What the mouse model has revealed about control of infection. Vet. Microbiol., 90, 367-382.
Belachew, A., Sordillo, E. M., & Seroogy, C. M. (2018). Multifaceted functions of B cells in the immune response against Mycobacterium tuberculosis. Frontiers in Immunology, 9, 2853. https://doi.org/10.3389/fimmu.2018.02853
Bosilkovski, M., Kirova-Urosevic, V., Cekovska, Z., & Labacevski, N. (2012). Role of interferon-gamma assay in differentiation between active and latent brucellosis. Clinical Laboratory, 58(9-10), 933-938.
Cannas, A., Calvo, L., Chiacchio, T., Cuzzi, G., Vanini, V., Lauria, F. N., ... & Goletti, D. (2017). IP-10 detection in urine is associated with lung diseases. BMC Infectious Diseases, 17(1), 1-7.
Casas, S., Chueca, M. A., Navarro, E., & Orduña, A. (2015). Evaluation of an in-house Brucella enzyme-linked immunosorbent assay for diagnosis of human brucellosis. Journal of Clinical Microbiology, 53(10), 3148-3154.
Corbel, M. J. (2006). Brucellosis in humans and animals. World Health Organization. Pappas,
Dasari, S., Naha, K., & Prabhu, M. (2013). Brucellosis and tuberculosis: clinical overlap and pitfalls. Asian Pacific Journal of Tropical Medicine, 6(10), 823–825. doi: 10.1016/S1995-7645(13)60145-5.
Dasari, V., Ravi Kumar, V., & Vuppu, S. (2013). Diagnostic evaluation of brucellosis in an endemic area of India. Journal of Clinical and Diagnostic Research, 7(12), 2902–2905.
Díaz, R., Casanova, A., Ariza, J., & Moriyón, I. (2011). The Rose Bengal Test in Human Brucellosis: A Neglected Test for the Diagnosis of a Neglected Disease. PLOS Neglected Tropical Diseases, 5(4), e950.
Dios-Diaz, P., Franco, M. P., López-Soria, L. M., et al. (2019). Human brucellosis in urban and rural areas: Different clinics for different patients. Tropical Medicine & International Health, 24(10), 1191–1197.
Durward, M., Radhakrishnan, G., Harms, J., Bareiss, C., Magnani, D., & Splitter, G. A. (2012). Active evasion of CTL mediated killing and low-quality responding CD8+ T cells contribute to persistence of brucellosis. PLoS One, 7(4), e34925. doi: 10.1371/journal.pone.0034925.
Franco, M. P., Mulder, M., & Gilman, R. H. (2007). Smits HL Human brucellosis. The Lancet Infectious Diseases, 7(12), 775-786.
G., Papadimitriou, P., Akritidis, N., Christou, L., & Tsianos, E. V. (2006). The new global map of human brucellosis. The Lancet Infectious Diseases, 6(2), 91-99.
Ghaznavi-Rad, E., Khosravi, K., Zarinfar, N., & Mosayebi, G. (2017). Reduced IFN-γ production in chronic brucellosis patients. Iranian Journal of Immunology, 14(3), 215–222.
Ghaznavi-Rad, E., Norouzian, M., & Mohebali, M. (2017). Immune response indicators to predict chronic brucellosis in humans. PLOS ONE, 12(5), e0178634. https://doi.org/10.1371/journal.pone.0178634
Hasanjani Roushan, M. R., Mohrez, M., & Smailnejad Gangi, S. M. (2007). Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiology and Infection, 135(2), 292–297.
Mariam Ayad Abd, Sawsan Q. T. Al-Quhli, Mahir Ali Jassim, (2024). Salmonella Biofilms And Antibiotic Resistance Determination From Different Patient Types, Journal of Angiotherapy, 8(2), 1-11, 9502
Martinez-Lopez, M., Iborra, S., & Conde-Garrosa, R. (2015). Microbiota sensing by mincle-syk axis in dendritic cells regulates interleukin-17 and− 22 production and promotes intestinal barrier integrity. Immunity, 44(3), 568-581.
Mengele, I. J., Shirima, G. M., Bronsvoort, B. M., Hernandez-Castro, L. E., & Cook, E. A. J. (2023). Diagnostic challenges of brucellosis in humans and livestock in Tanzania: A thematic review. CABI One Health, 2023(1), 1-16. https://doi.org/10.1079/cabionehealth.2023.0001
Mert, A., Ozaras, R., Tabak, F., et al. (2003). The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis, 46(4), 241–243. doi: 10.1016/s0732-8893(03)00081-6.
Mohseni, K., Mirnejad, R., Piranfar, V., & Mirkalantari, S. (2017). A Comparative Evaluation of ELISA, PCR, and Serum Agglutination Tests For Diagnosis of Brucella Using Human Serum. Iran J Pathol, 12(4), 371–376.
Pappas, G., Akritidis, N., Bosilkovski, M., & Tsianos, E. (2005). Brucellosis. New England Journal of Medicine, 352(22), 2325-2336.
Rahmanpour, M., Keramat, F., Jourghasemi, S., Rashidi, G., Abdolmaleki, M., Solgi, G., & Hajilooi, M. (2019). Direct correlation between Th1 and Th17 responses in immunity to Brucella infection. 21(10), 441-448.
Rodriguez-Zapata, M., Matias, M. J., & Prieto, A. (2010). Diagnostic yield of a PCR assay in focal complications of brucellosis. Journal of Infection, 61(3), 204–206.
Rodriguez-Zapata, M., Matias, M. J., Prieto, A., et al. (2010). Human brucellosis is characterized by an intense Th1 profile associated with defective monocyte function. Infection and Immunity, 78(7), 3272–3279. doi: 10.1128/IAI.01385-09.
Seleem, M. N., Boyle, S. M., & Sriranganathan, N. (2010). Brucellosis: a re-emerging zoonosis. Veterinary Microbiology, 140(3-4), 392-398.
Skendros, P., Pappas, G., & Boura, P. (2011). Cell-mediated immunity in human brucellosis. Microbes and Infection, 13(2), 134–142. doi: 10.1016/j.micinf.2010.10.015.
Xu, G., Zhang, P., Dang, R., Jiang, Y., Wang, F., ... Yang, M. (2019). Dynamic changes of Th1 cytokines and the clinical significance of the IFN-γ/TNF-α ratio in acute brucellosis. Mediators Inflamm., 2019, 5869257. doi: 10.1155/2019/5869257.
Xu, L., Wang, Y., Huang, S., Li, H., & Chen, H. (2019). Association of interferon-gamma level with chronic brucellosis. Medical Science Monitor, 25, 6832–6837. https://doi.org/10.12659/MSM.916699
View Dimensions
View Altmetric
Save
Citation
View
Share